Drug Database · Clinicians

Ketoconazole

Brands (49) Dermazole, Ketovid, Nizoral…Show all

US brand (reference label): Ketodan; not a Philippine-registered brand.

Azole Antifungal (Cytochrome P450 3A4 Inhibitors; Cytochrome P450 3A5 Inhibitors; P-Glycoprotein Inhibitors) US FDA class
Antifungal (imidazole and triazole derivatives); Antifungal for topical use (imidazole and triazole); and others PH FDA category

Rx · Prescription drugOTC · Over-the-counterHR · Household remedy65 PH productsPNF-listedPhilHealth GAMOT
Dispensing: Household remedy (HR) · Over-the-counter (OTC) · Prescription (Rx) Last updated: Audience: Licensed health professionals
Label text on this page: US FDA-approved label via DailyMed/openFDA, set ID 62f19bd8-926e-4e6b-9097-d81b894b95cc, version date December 5, 2024 (Ketodan · Medimetriks Pharmaceuticals, Inc.). Reproduced verbatim. Philippine-approved indications and doses may differ: check the PH package insert.

Use: Labeled indications

  • 1.
US FDA label
Full indications and usage US FDA label

1. INDICATIONS AND USAGE Ketodan ® Foam, 2% is indicated for the topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older. Ketodan ® Foam, 2% is indicated for topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older (1). Limitations of Use Safety and efficacy of Ketodan ® Foam, 2% for treatment of fungal infections have not been established. Limitations of Use Safety and efficacy of Ketodan ® Foam, 2% for treatment of fungal infections have not been established.

Contraindications

4. CONTRAINDICATIONS None. None.

US FDA label

Dosing: Adult

Dosage and administration (US label) US FDA label

2. DOSAGE AND ADMINISTRATION Ketodan ® Foam, 2% should be applied to the affected area(s) twice daily for four weeks. Hold the container upright, and dispense Ketodan ® Foam, 2% into the cap of the can or other cool surface in an amount sufficient to cover the affected area(s). Dispensing directly onto hands is not recommended, as the foam will begin to melt immediately upon contact with warm skin.

Pick up small amounts of Ketodan ® Foam, 2% with the fingertips, and gently massage into the affected area(s) until the foam disappears. For hair-bearing areas, part the hair, so that Ketodan ® Foam, 2% may be applied directly to the skin (rather than on the hair). Avoid contact with the eyes and other mucous membranes. Ketodan ® Foam, 2% is not for ophthalmic, oral or intravaginal use.

Ketodan ® Foam, 2% should be applied to the affected area(s) twice daily for four weeks (2). Ketodan ® Foam, 2% is not for ophthalmic, oral, or intravaginal use (2).

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosing: Pediatric

Pediatric use (US label) US FDA label

8.4 Pediatric Use The safety and effectiveness of ketoconazole foam, 2% in pediatric patients less than 12 years of age have not been established. Of the 672 subjects treated with ketoconazole foam, 2% in the clinical trials, 44 (7%) were from 12 to 17 years of age. [See Clinical Studies (14)].

Dosing: Older adult

Geriatric use (US label) US FDA label

8.5 Geriatric Use Of the 672 subjects treated with ketoconazole foam, 2% in the clinical trials, 107 (16%) were 65 years and over. Clinical trials of ketoconazole foam, 2% did not include sufficient numbers of subjects aged 65 and over to determine whether they respond differently than younger subjects.

Dosage forms

Philippines

  • Cream: 20 mg/g
  • Topical cream: 20 mg/g
  • Shampoo: 20 mg/g, 20 mg/mL
  • ) cream: 20 mg/g

Registered products in the Philippines

65 products registered with the Food and Drug Administration (FDA) Philippines list Ketoconazole as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

All registered products65
Philippine FDA-registered products for Ketoconazole
Package insert
ConagenKetoconazole
20mg/g (2%) Topical CreamAluminum tube with HDPE Screw Cap x 5g, 10g, and 15g (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories Inc.,Philippines
Trader: Eba Generisch Trading Inc.
DRP-14745
Dec 21, 2028
DerkazoleKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 15 g
OTC
Lincoln Pharmaceuticals Ltd.India
Despina Pharma Inc.
DRP-12567
Sep 2, 2027
DermazoleKetoconazole
20 mg / mL (2% w/v) ShampooAluminum Foil Sachet X 8 mL (Box of 20's)
HR
Kusum Healthcare Private LimitedIndia
Kusum Healthcare Private Limited Branch Office
DRHR-1992
May 26, 2030
DermazoleKetoconazole
20 mg/mL (2% w/v) ShampooHDPE Bottle X 60 HDPE Bottle x 60 mL (50 mL net content) and 120 mL (100 mL net content)mL (50 mL Net Content) (Box of 1's)
HR
Kusum Healthcare Pvt. Ltd.India
Kusum Healthcare Private Limited Branch Office
DRHR-1632
Feb 9, 2031
DermsurKetoconazole
20 mg/mL (2% w/v) ShampooPET Bottle with Cap x 60 mL and 100 mL (Box of 1's)
HR
Nanz Med Science Pharma Pvt. Ltd.India
Pharma-Surrey International Inc.
HRP-695
May 22, 2030
EnnazoleKetoconazole
20 mg/g (2% w/w) CreamAluminum Tube x 15g (Box of 1's)
OTC
S Kant Healthcare LimitedIndia
Bellus Life Solutions, IncImporter: Aglobal Care, Inc.
DRP-11793-01
Apr 29, 2027
FungazoneKetoconazole
20 mg/g (2% w/w) CreamLaminated Tube with White Cap x 15 g (Box of 1's)
OTC
Uniza Lifecare Pvt. Ltd.India
Lealmeds Pharmaceutical Inc.\Trader: M/S Pharmacare
DRP-15195
Jun 7, 2029
FungelleKetoconazole
20 mg/g (2% w/w) CreamAluminum Tube x 15g (Box of 1's)
OTC
S Kant Healthcare Ltd.India
GA2 Pharmaceutical IncImporter: Medinova Pharmaceutical Inc.
DRP-14803-03
Jan 11, 2029
Funginil-KKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Sotac Pharmaceuticals Pvt. Ltd.India
Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd.
DRP-3821
Jun 29, 2027
FungiselKetoconazole
20 mg/g (2% w/w) CreamAluminum Tube x 15 g (Box of 1's)
OTC
S Kant Healthcare Ltd.India
New Seammed IncImporter: Medinova Pharmaceutical Inc.
DRP-14803-02
Jan 11, 2029
Go-KetoKetoconazole
20 mg/g (2% w/w) Topical CreamAluminum Tube x 15g (Box of 1's)
OTC
S Kant Healthcare LimitedIndia
Applied Pharmaceutical Distribution Inc.Importer: Orange Biotec Inc.
DRP-11476-01
Mar 30, 2027
GonazolKetoconazole
20 mg/g (2% w/w) CreamAluminum Tube x 15 g (Box of 1's)
OTC
S Kant Healthcare Ltd.India
Applied Pharmaceutical Distribution IncImporter: Medinova Pharmaceutical Inc.
DRP-14803-01
Jan 11, 2029
Healthcare Antifungal CreamKetoconazole
2% (20 mg/g) CreamAluminum Tube x 10 g (Box of 1's)
Rx
Lloyd Laboratories, Inc.Philippines
—
DR-XY38892 (For Export Only)
Dec 23, 2030
ItcheketKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Sotac Pharmaceuticals Pvt. Ltd.India
Diafarm Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd.
DRP-3821-04
Jun 29, 2027
K-ZolKetoconazole
20 mg/g (2% w/w Cream10 g and 15 g Aluminum Collapsible Tube with Cap (Box of 1's)
OTC
Yash Medicare Private LimitedIndia
Aglobal Care, Inc.Trader: Antila Lifesciences Pvt. Ltd.
DR-XY46666
Jul 31, 2029
KeedermKetoconazole
20 mg/g (2% w/w) Cream20 Grams
OTC
West-Coast Pharmaceuticals Works Pvt. Ltd.India
Allegens Healthcare Philippines Inc.
DRP-18977
Oct 12, 2031
Kenz CreamKetoconazole
20mg/g (2% w/w/) CreamLaminated Tube x 10g & 15g (Box of 1's)
OTC
KLM Laboratories Pvt. Ltd.India
AMB HK Enterprises Inc.
DRP-13661
Mar 29, 2028
KermazoneKetoconazole
20 mg/g (2% w/w) CreamLaminated Aluminum Tube x 10 g (Box of 1's)
OTC
Scott-Edil Pharmacia LimitedIndia
Despina Pharma Inc.
DRP-17363
Nov 25, 2030
KetakinKetoconazole
20 mg/g (2%) Topical CreamAluminum Collapsible Tube x 10 g (Box of 1's); Aluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Nanjing Baijingyu Pharmaceutical Co., Ltd.China
Global Pharmatrade
DR-XY42537
Sep 6, 2028
KetazfloxKetoconazole
20 mg/g (2% w/w) Topical Cream.Laminated Tube x 30g (Box of 1's)
OTC
Daiwik Pharmasphere Pvt. Ltd.India
FSPC Pharmaceuticals Inc.
DRP-14868
Jan 25, 2029
KeteenKetoconazole
20 mg/g (2 % w/v) ShampooHDPE Bottle x 75 mL (Box of 1's)
Rx
Curetech SkincareIndia
Ambica International Corporation
HRP-422
Apr 16, 2030
KetmaKetoconazole
20mg/g (2% w/w) Topical CreamAluminum Tube x 10g (Box of 1's)
OTC
Rhydburg Pharmaceuticals Ltd.India
Genedrift Philippines OPC
DRP-14869
Jan 25, 2029
KetoconasaphKetoconazole
20 mg/g (2% w/w) ShampooFoil Sachet x 6 mL (Box of 48's)
OTC
Azine Healthcare Pvt. Ltd.India
Ollen Pharma Trading Inc.
DRP-12397
Aug 1, 2027
KetoconazanKetoconazole
20 mg/g (2%) Topical CreamAluminum tube with HDPE Screw Cap x 5g, 10g, and 15g (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories IncPhilippines
Triple 888 Medical And Pharma Inc.
DRP-14698-01
Nov 29, 2028
KetocorexKetoconazole
20mg/g (2% w/w) Topical CreamAluminum Collapsible Tube x 10g, 15g, and 20g (Box of l’s)
OTC
Next Wave (India)India
Aarex Pharma Distributor
DRP-12387
Jul 29, 2027
KetofredKetoconazole
20mg/g (2% w/w) Topical CreamLaminated Tube x 15g (Box of 1's)
OTC
Fredun Pharmaceuticals LimitedIndia
AMB HK Enterprises Inc.
DRP-14870
Jan 25, 2029
KetohabKetoconazole
20mg/g (2% w/w) Topical CreamAluminum Tube x 10g (Box of 1’s)
OTC
Dae Hwa Pharmaceutical Co., Ltd.Korea
H & B Pharma International Inc.
DRP-12386
Jul 29, 2027
KetoprimeKetoconazole
20 mg/g (2% w/w) Topical CreamAluminium Tube x 3.5g, 5g, 10g, 15g, 20g, and 30g (Box of 1's)
OTC
Primecare Lifesciences Laboratories Corp.Philippines
Trader: Life and Health Source Pharmaceutical Distribution Co.
DRP-15439
Aug 1, 2029
KetosorbKetoconazole
20 mg/g (2% w/w) CreamLaminated Tube x 10 g (Box of 1's)
OTC
Rhydburg Pharmaceuticals Ltd.India
Pharmastar Int'l Trading Corp.Trader: Sheer Essentials
DRP-16875
Aug 6, 2030
KetovenasolKetoconazole
20 mg/g (2% w/w) Topical CreamHDPE Collapsible Tube x 15 g (Box of 1's)
OTC
Gracure Pharmaceuticals Ltd.,India
AGlobal Care Inc.Importer: Aglobal Care, Inc.
DRP-15848
Sep 23, 2029
KetovidKetoconazole
20 mg/g (2% w/w) CreamAluminum Tube x 5 g and 15 g
Rx
Hovid Bhd.Malaysia
Hovid, Inc.
DR-XY32502
Nov 6, 2031
KetovidKetoconazole
20 mg/g (2% w/w) ShampooHDPE Bottle x 120 mL Box of 1's
HR
Hovid BerhadMalaysia
HOVID INC
DRHR-1801
Sep 29, 2027
KetoxolKetoconazole
20mg/g (2%) Topical CreamAluminum tube with HDPE Screw Cap x 5g, 10g, and 15g (Box of 1's)
OTC
Azarias Pharmaceutical Laboratories Inc.,Philippines
—
DRP-14698
Nov 29, 2028
KetozolKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 5 g and 15 g (Box of 1's)
Rx
Bal Pharma LimitedIndia
Endure Medical Inc.Importer: Singapore Genebio Inc.
DR-XY43328
Apr 1, 2029
KetsokantKetoconazole
20 mg/g (2% w/w) CreamAluminum Tube x 15g (Box of 1's)
OTC
S Kant Healthcare LimitedIndia
Aglobal Care, Inc.
DRP-11793
Apr 29, 2027
KezoKetoconazole
2% w/v Topical CreamAluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Mediwin PharmaceuticalsIndia
Ambica International Corporation
DRP-4513
Jul 18, 2028
KezoleKetoconazole
20mg/g (2% w/w) Topical CreamLaminated Tube x 5 g (Box of 1's) Laminated Tube x 10 g (Box of 1's) Laminated Tube x 15 g (Box of 1's)
Rx
Zee Laboratories LimitedIndia
Eon Pharmatek Inc.
DR-XY48644
Mar 9, 2028
KrenazolKetoconazole
20 mg/g (2% W/W) CreamLaminated Tube X 30g (Box of 1's)
OTC
Kremoint Pharma Pvt. Ltd.India
Aglobal Care, Inc.
DRP-12189
Jun 28, 2032
KzoleKetoconazole
20mg/g (2% w/w) Topical CreamAluminum Tube x 15g (Box of 1's)
OTC
S. Kant Healthcare LimitedIndia
Suhitas Pharmaceuticals Inc.
DRP-11476
Mar 30, 2027
LatosilKetoconazole
20 mg/g CreamAluminum Tube x 5 g Box of 1’s
OTC
T.O. Chemicals (1979) Ltd.Thailand
Lordla Pharma Sales
DR-XY25062
Apr 14, 2029
MeedzoleKetoconazole
20 mg/g (2% w/w) Topical CreamAluminum Tube x 5g (Box of 1's)
OTC
Lloyd Laboratories, Inc.Philippines
Medical Supplies & Equipment DistributorTrader: Euro-Health Care Exponents, Inc.
DRP-2532-02
Mar 15, 2029
NekozolKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 15 g
OTC
Lincoln Pharmaceuticals Ltd.India
Epione Lifecare Inc.Importer: Despina Pharma Inc.
DRP-12567-01
Sep 2, 2027
NeoconazolKetoconazole
20 mg / g (2% w/w) Topical CreamLaminated Tube x 15 g (Box of 1's)
Rx
Zee Laboratories LimitedIndia
Eon Pharmatek Inc.
DRP-15050
Mar 9, 2028
NizochemKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube with milky white cap having a piercing point x 15 g (Box of 1’s)
Rx
S Kant Healthcare LtdIndia
Wellchem Pharmaceutical Products
DRP-10225
Aug 12, 2031
NizoralKetoconazole
20 mg/g (2% w/w) CreamAluminum Tube x 3.5 g, 5 g and 10 g (Box of 1's)
HR
Interphil Laboratories, Inc.Philippines
Trader: Johnson & Johnson (Phils.), Inc.
DRHR-423
Feb 10, 2027
NizoralKetoconazole
20 mg/g (2%) ShampooFoil Sachet x 6 mL (Box of 48's)
Rx
Interphil Laboratories, Inc.Philippines
Zuellig Pharma Corporation
DRHR-402
Apr 18, 2031
NoneKetoconazole
2 % w/v Topical CreamAluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Mediwin PharmaceuticalsIndia
Actimed, Inc.Importer: Ambica International Corporation
DRP-4513-01
Jul 18, 2028
NoneKetoconazole
2 % w/v Topical CreamAluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Mediwin PharmaceuticalsIndia
TGP Pharma Inc.Importer: Ambica International Corporation
DRP-4513-02
Jul 18, 2028
NoneKetoconazole
2% w/v Topical CreamAluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Mediwin PharmaceuticalsIndia
PharmaVital Corp.Importer: Ambica International Corporation
DRP-4513-03
Jul 18, 2028
NoneKetoconazole
20 mg/ g ShampooAluminum sachet x 6 mL Box of 48's
Rx
Amherst Laboratories, Inc.Philippines
Trader: Ritemed Phils., Inc.
DRHR-1931
Jul 22, 2029
NoneKetoconazole
20 mg/ g ShampooHDPE Bottle x 60 mL
HR
Amherst Laboratories, Inc.Philippines
Trader: RITEMED PHILS., INC.
DRHR-1932
Jul 22, 2029
NoneKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Sotac Pharmaceuticals Pvt. Ltd.India
Ambicare Pharmaceuticals Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd.
DRP-3821-02
Jun 29, 2027
NoneKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 15 g Box of 1's
Rx
Sotac Pharmaceuticals Pvt. Ltd.India
TGP Pharma Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd.
DRP-3821-03
Jun 29, 2027
NoneKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 15 g Box of 1's
Rx
Sotac Pharmaceuticals Pvt. Ltd.India
Actimed, Inc.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd.
DRP-3821-05
Jun 29, 2027
NoneKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 15 g (Box of 1's)
Rx
Sotac Pharmaceuticals Pvt. Ltd.India
ATC Healthcare International Corp.Importer: Ambica International CorporationTrader: Stallion Laboratories Pvt. Ltd.
DRP-3821-06
Jun 29, 2027
NoneKetoconazole
20 mg/g (2% w/w) Topical CreamAluminum Tube x 5 g and 15 g (Box of 1's)
Rx
Lloyd Laboratories, Inc.Philippines
TGP Pharma Inc.Trader: Euro-Health Care Exponents, Inc.
DRP-2532
Mar 15, 2029
NovazolKetoconazole
20 mg/g (2% w/w) CreamAluminum Tube x 15g (Box of 1's)
OTC
S Kant Healthcare Ltd.India
Medinova Pharmaceutical, Inc.
DRP-14803
Jan 11, 2029
PhytoralKetoconazole
20 mg/g (2% w/w Ointment)Aluminum Tube x 15 g (Box of 1's)
Rx
Micro Labs LimitedIndia
Brown & Burk Philippines Inc.
DR-XY29106
Oct 20, 2031
PorazoleKetoconazole
20mg/g (2% w/w) CreamAluminum Collapsible Tube x 5 g, 10 g, 15 g, 20 g, 30 g (Box of 1's)
Rx
Kwality Pharmaceutical Ltd.India
Pors Pharma Trading
DRP-14177
Jul 14, 2028
RetaconazolKetoconazole
20 mg / g (2% w/w) CreamAluminum Tube x 15 g (Box of 1's)
OTC
S Kant Healthcare LimitedIndia
Reta DrugImporter: Aglobal Care, Inc.
DRP-11793-02
Apr 29, 2027
SaphconazoleKetoconazole
20 mg/g (2% w/w) Cream10 g, 15 g and 20 g Aluminum Collapsible Tube (Box of 1's)
Rx
Azine Healthcare Pvt. Ltd.India
Nelpa Lifesciences, Inc.
DRP-13348
Feb 2, 2028
UnbrandedKetoconazole
20 mg/ g (2% w/w) CreamAluminum Collapsible Tube with Polypropylene Cap x 3.5 g and 5 g (Box of 1's)
OTC
Amherst Laboratories, Inc.Philippines
Trader: Ritemed Phils., Inc.
DR-XY29094
Oct 27, 2031
UnbrandedKetoconazole
20mg/g (2% w/w) Cream10g Aluminum Collapsible Tube
Rx
M.C.B. Dermatological ProductsPhilippines
—
DR-XY45422
Jun 1, 2031
ZoloralKetoconazole
20 mg/g (2% w/w) CreamAluminum Collapsible Tube x 10 g
OTC
PT. Ikhapharmindo PutramasIndonesia
Exa Life Care Pharma Inc.
DRP-17098
Sep 25, 2030
(no brand name)Ketoconazole
20 mg/g (2%) ShampooHDPE Bottle with PP cap x 50mL
HR
OLIC (Thailand) LimitedThailand
Zuellig Pharma CorporationTrader: Alliance Pharmaceuticals Limited
DRHR-2476
Oct 24, 2030

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

United States (label)

Dosage forms and strengths (US label) US FDA label

3. DOSAGE FORMS AND STRENGTHS Ketodan ® Foam, 2% contains 20 mg of ketoconazole, USP per gram, supplied in 100 g containers. Foam: 2% ketoconazole in 100 g containers (3).

Warnings/Precautions

Warnings and precautions (US label) US FDA label

5. WARNINGS AND PRECAUTIONS Ketodan ® Foam, 2% may result in contact sensitization, including photoallergenicity (5.1, 6.2). The contents of Ketodan ® Foam, 2% are flammable. Avoid fire, flame, or smoking during and immediately following application. (5.2).

5.1 Contact Sensitization Ketodan

5.1 Contact Sensitization Ketodan ® Foam, 2% may result in contact sensitization, including photoallergenicity [see Adverse Reactions (6.2)].

5.2 Flammable Contents

5.2 Flammable Contents The contents of Ketodan ® Foam, 2% include alcohol and propane/butane, which are flammable. Avoid fire, flame and/or smoking during and immediately following application. Do not puncture and/or incinerate the containers. Do not expose containers to heat and/or store at temperatures above 120°F (49°C).

5.3 Systemic Effects

5.3 Systemic Effects Hepatitis has been seen with orally administered ketoconazole (1:10,000 reported incidence). Lowered testosterone and ACTH–induced corticosteroid serum levels have been seen with high doses of orally administered ketoconazole. These effects have not been seen with topical ketoconazole.

Adverse reactions

Adverse reactions (US label) US FDA label

6. ADVERSE REACTIONS The most common adverse reactions observed in clinical studies (incidence >1%) were application site burning and application site reaction (6.1). To report SUSPECTED ADVERSE REACTIONS, contact Medimetriks at 1-973-882-7512 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

6.1 Clinical Trials Experience

6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug, and may not reflect the rates observed in practice. The adverse reaction information from clinical trials does, however, provide a basis for identifying the adverse reactions that appear to be related to drug use and for approximating rates.

The safety data presented in Table 1 reflect exposure to ketoconazole foam, 2% in 672 subjects, 12 years and older with seborrheic dermatitis. Subjects applied ketoconazole foam, 2% or vehicle foam twice daily for 4 weeks to affected areas on the face, scalp, and/or chest. Adverse reactions occurring in > 1% of subjects are presented in Table 1.

Table 1: Adverse Reactions Reported by > 1% Subjects in Clinical Trials Adverse Reactions Ketoconazole Foam, 2% N = 672 n (%) Vehicle Foam N = 497 n (%) Subjects with an Adverse Reaction 188 (28%) 122 (25%) Application site burning 67 (10%) 49 (10%) Application site reaction 41 (6%) 24 (5%) Application site reactions that were reported in <1% of subjects were dryness, erythema, irritation, paresthesia, pruritus, rash and warmth.

6.2 Dermal Safety Studies

6.2 Dermal Safety Studies In a photoallergenicity study, 9 of 53 subjects (17%) had reactions during the challenge period at both the irradiated and non-irradiated sites treated with ketoconazole foam, 2%. Ketodan ® Foam, 2% may cause contact sensitization.

6.3 Postmarketing Experience

6.3 Postmarketing Experience The following adverse events have been identified during postmarketing use of ketoconazole foam, 2%: Gastrointestinal disorders: Cheilitis General disorders and administration site conditions: Application site pain and application site burn Skin and subcutaneous tissue disorders: Skin burning sensation and erythema Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

Adverse reaction frequency tables (US label) US FDA label
Table 1: Adverse Reactions Reported by > 1% Subjects in Clinical Trials
Adverse ReactionsKetoconazole Foam, 2% N = 672 n (%)Vehicle Foam N = 497 n (%)
Subjects with an Adverse Reaction188 (28%)122 (25%)
Application site burning67 (10%)49 (10%)
Application site reaction41 (6%)24 (5%)

Pregnancy considerations

Pregnancy (US label) US FDA label

8.1 Pregnancy Risk Summary There are no available data on ketoconazole foam, 2% use in pregnant women to identify a drug-associated risk of major birth defects, miscarriage or adverse maternal or fetal outcomes. No reproductive studies in animals have been performed with ketoconazole foam, 2%. In animal reproduction studies with pregnant mice, rats and rabbits both embryotoxic and developmental effects (structural abnormalities) were observed following oral dosing of ketoconazole during organogenesis.

Assuming equivalent systemic absorption of topical and oral ketoconazole doses and a ketoconazole foam, 2% maximum recommended human dose (MRHD) of 8 grams (equivalent to 160 mg ketoconazole), embryotoxic effects were observed at 0.8 to 2.4 times the MRHD and developmental effects were observed at 4.8 times the MRHD [see Data]. The background risk of major birth defects and miscarriage for the indicated population is unknown.

All pregnancies have a background risk of birth defect, loss, or other adverse outcomes. In the U.S. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2 to 4% and 15 to 20%, respectively. Data Animal Data The animal multiples of human exposure calculations are based on body surface area (BSA) comparisons of oral doses administered to animals and a ketoconazole foam, 2% maximum recommended human dose (MRHD) of 8 grams (equivalent to 2.67 mg ketoconazole/kg/day for a 60 kg individual or 98.8 mg ketoconazole/m 2 /day).

Embryofetal development studies have been conducted in mice, rats and rabbits with orally administered ketoconazole. When orally administered to mice on gestational days 6 through 18 (covering the period of organogenesis), ketoconazole was embryotoxic (25 mg/kg and higher; 0.8 times the MRHD based on BSA comparisons) with a high incidence of resorptions, increased number of stillbirths and delayed parturition.

Delays in maturation were also observed. There was no evidence of maternal toxicity or malformations at up to 50 mg/kg (1.5 times the MRHD based on BSA comparisons). No treatment related developmental effects were observed at 10 mg/kg (0.3 times the MRHD based on BSA comparisons). In the presence of maternal toxicity in rats, orally administered ketoconazole was both embryotoxic (40 mg/kg and higher; 2.4 times the MRHD based on BSA comparisons), including increased resorbed fetuses and stillbirths, and teratogenic (80 mg/kg and higher; 4.8 times the MRHD based on BSA comparisons), including syndactylia, oligodactylia, waved ribs and cleft palate.

Additionally, 100 mg/kg (6 times the MRHD based on BSA comparisons) ketoconazole orally administered on a single day during gestation (gestational days 9 through 12) was embryotoxic (increased resorptions). This same oral dose given on gestation day 12, 13, 14 or 15 induced external malformations including cleft palate, micromelia and digital anomalies (brachydactyly, ectrodactyly, syndactyly).

In pregnant rabbits orally administered ketoconazole, evidence of embryotoxicity (increased resorptions) was observed at 10 mg/kg (1.2 times the MRHD based on BSA comparisons) and higher and an increased incidence of skeletal abnormalities was observed at 40 mg/kg (4.8 times the MRHD based on BSA comparisons).

Mechanism of action

12.1 Mechanism of Action The mechanism of action of ketoconazole in the treatment of seborrheic dermatitis is not known.

US FDA label

Pharmacodynamics

Pharmacodynamics (US label) US FDA label

12.2 Pharmacodynamics The pharmacodynamics of Ketodan ® Foam, 2% has not been established.

Pharmacokinetics

Pharmacokinetics (US label) US FDA label

12.3 Pharmacokinetics In a bioavailability study, 12 subjects with moderate to severe seborrheic dermatitis applied 3 g of ketoconazole foam, 2% twice daily for 4 weeks. Circulating plasma levels of ketoconazole were < 6 ng/mL for a majority of subjects (75%), with a maximum level of 11 ng/mL observed in one subject.

Formulary and pricing (Philippines)

Government price references

PreparationPrice (PHP)UnitType
Ketoconazole 2%, 15 g aluminum tube₱67.33–₱115.00Reference ₱78.00per tubeDPRI procurement range
2% (20 mg/g) cream in 15 g aluminum collapsible tube₱91.50per tubePhilHealth GAMOT fixed fee
2% (20 mg/g) cream in 3.5 g aluminum collapsible tube₱118.75per tubePhilHealth GAMOT fixed fee
2% (20 mg/g) shampoo in 100 mL bottle₱433.50per bottlePhilHealth GAMOT fixed fee
2% (20 mg/g) shampoo in 6 mL foil sachet₱51.75per sachetPhilHealth GAMOT fixed fee
2% (20 mg/g) shampoo in 60 mL bottle₱242.25per bottlePhilHealth GAMOT fixed fee

PhilHealth GAMOT fixed fee paid to the accredited GAMOT pharmacy per unit dispensed Range = lowest-highest procurement price (highest usable only in GIDA areas); reference_price = 2021 DPRI ceiling (median)

These are government procurement and reimbursement references, not retail prices. Sources:

Formulary and coverage

Philippine National FormularyListed as Ketoconazole
PNF listingCream: 2% (20 mg/ g), 3.5 g and 15 g aluminum collapsible tube
PNF listingShampoo: 2% (20 mg/ g), 6 mL foil sachet, 10 mL, 60 mL and 100 mL bottle
PhilHealth GAMOTYes (listed since July 28, 2025)

Sources:

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. U.S. Food and Drug Administration. Ketodan · Medimetriks Pharmaceuticals, Inc. [US FDA-approved label, version 8, December 5, 2024]. Via DailyMed/openFDA. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=62f19bd8-926e-4e6b-9097-d81b894b95cc
  2. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph
  3. PNF Essential Medicines List, 8th ed. (as of November 2, 2022), DOH; https://www.philhealth.gov.ph/partners/providers/pdf/PNF-EML_11022022.pdf
  4. PhilHealth Circular No. 2026-0018, Expanding Access to Outpatient First-line Anti-TB Drugs through PhilHealth GAMOT, Annex A.i GAMOT List (81 molecules); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  5. PhilHealth Circular No. 2026-0018, Annex A.2 GAMOT Fixed Fee Schedule (249 preparations; fees otherwise unchanged from PC2025-0013); https://www.philhealth.gov.ph/circulars/2026/PC-2026-0018.pdf
  6. DOH Drug Price Reference Index (DPRI) 2021, 9th edition (as of September 17, 2021); https://caro.doh.gov.ph/wp-content/uploads/2021/09/2021DPRI-as-of-9-17-2021.pdf

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .